2. CONTENTS :
• Introduction
• Ideal characteristics
• Advantages
• Disadvantages
• Carrier ormarkers
• Strategies of drug targeting
• Types of targeted drug delivery system
3. INTRODUCTION :
‘Targeted drug delivery system is a special form of drug
delivery system where the medicament is selectively
targeted or delivered only to its site of action or
absorption and not to the non-target organs or tissues or
cells.’
•It is a method of delivering medication to a patient in a
manner that increases the concentration of the medication
in some parts of the body relative to others.
•Targeted drug delivery seeks to concentrate themedication
in the tissues of interest while reducing the relative
concentration of the medication in the remainingtissues.
• This improves efficacy and reduce side effects.
4. THE DRUG MAYBE DELIVERED :
•Tothe capillary bed of the active sites.
•Tothe specific type of cell (or) even an intracellular
region. Ex: Tumour cells but not to normalcells.
•To a specific organ (or) tissues by complexion with the
carrier that recognizes the target.
OBJECTIVE :
•Toachieve a desired pharmacological response at a
selected sites without undesirable interaction at othersites,
there by the drug have a specific action with minimum
side effects & better therapeutic index.
•Ex- In cancer chemotherapy and enzyme replacement
therapy.
5. REASON FOR DRUG TARGETING :
•In the treatment or prevention or diseases.
•Pharmaceutical drug instability in conventional dosage
form solubility ,biopharmaceutical low absorption, high-
membrane bounding, biological instability,
pharmacokinetic / pharmacodynamic short half life, large
volume of distribution, low specificity, clinical, low
therapeutic index.
6. IDEAL CHARACTERISTICS :
•It should be nontoxic, biocompatible, biodegradable,
and physicochemical stable invivo and invitro.
•Restrict drug distribution to target cells or tissues or
organs and should have uniform capillarydistribution.
• Controllable and predicate rate of drug release.
• Drug release does not effect the drug action.
• Therapeutic amount of drug release.
• Minimal drug leakage during transit.
•Carriers used must be bio-degradable or readily
eliminated from the body without any problem andno
carrier induced modulation of diseased state.
•The preparation of the delivery system should be easyor
reasonably simple, reproductive and cost effective.
7. ADVANTAGES :
•Drug administration protocols may be simplified.
•Toxicity is reduced by delivering a drug to its targetsite,
there by reducing harmful systemic effects.
•Drug can be administered in a smaller dose to producethe
desire effect.
• Avoidance of hepatic first pass metabolism.
•Enhancement of the absorption of target molecules suchas
peptides and particulates.
•Dose is less compared to conventional drugdelivery
system.
•No peak and valley plasma concentration.
•Selective targeting to infections cells that compareto
normal cells.
8. DISADVANTAGES :
•Rapid clearance of targeted systems.
•Immune reactions against intravenous administeredcarrier
systems.
•Insufficient localization of targeted systems into tumour
cells.
•Diffusion and redistribution of released drugs.
•Requires highly sophisticated technology forthe
formulation.
•Requires skill for manufacturing storage, administration.
•Drug deposition at the target site may produce toxicity
symptoms.
•Difficult to maintain stability of dosage form.
E.g.: Resealed erythrocytes have to be stored at 40C.
•Drug loading is usually law. E.g.As in micelles.Therefore
it is difficult to predict /fix the dosage regimen.
9. CARRIER OR MARKERS :
•Targeted drug delivery can be achieved by using
carrier system.
•Carrier is one of the special molecule or system
essentially required for effective transportation ofloaded
drug up to the pre selected sites.
•They are engineered vectors, which retain drug inside or
onto them either via encapsulation and/ or via spacermoiety
and transport or deliver it into vicinity of target cell.
Pharmaceutical carriers :
Polymers
Microcapsules
Microparticles
Lipoproteins
Liposomes
Micelles
10. 1) Passive Targeting :
• Drug delivery systems which are targeted to
systemic circulation are characterized as Passive
delivery systems.
• In this technique drug targeting occurs because of the
body’s natural response to physicochemical
characteristics of the drug or drug carriersystem.
11. 2) Inverse Targeting :
•In this type of targeting attempts are made to avoid
passive uptake of colloidal carrier by RES (Reticulo
Endothelial Systems) and hence the process is referred
to as inverse targeting.
•To achieve inverse targeting, RES normal function is
suppressed by pre injecting large amount of blank
colloidal carriers or macromolecules like dextran
sulphate
•Thisapproach leads to saturation of RES and
suppression of defence mechanism. This type oftargeting
is a effective approach to target drug(s) to non-RES
organs.
12. 3)Active Targeting :
• In this approach carrier system bearing drug
reaches to specific site on the basis of
modification made on its surface rather than
natural uptake by RES.
• Surface modification technique include coating of
surface with either a bioadhesive, nonionic
surfactant or specific cell or tissue antibodies (i.e.
monoclonal antibodies) or by albumin protein.
3 Types
o First order targeting (organ compartmentalization).
o Second order targeting (cellular targeting).
o Third order targeting (intracellular targeting).
13. 4)Ligand Mediated Targeting : Achieved using
specific mechanisms such as receptor dependent uptakeof
natural LDL particles and synthetic lipid microemulsions
of partially reconstituted LDL particles coated with the
apoproteins.
5)Physical Targeting :
•In this type of targeting some characteristics of
environment changes like pH, temperature, light
intensity, electric field, ionic strength small and even
specific stimuli like glucose concentration are used to
localize the drug carrier to predetermined site.
•This approach was found exceptional for tumour
targeting as well as cytosolic delivery of entrapped drugor
genetic material.
14. 6) Dual Targeting :
• In this targeting approach carrier molecule itself
have their own therapeutic activity and thus
increasethe therapeutic effect of drug.
• For example, a carrier molecule having its own
antiviral activity can be loaded with antiviral drugand
the net synergistic effect of drug conjugate was
observed.
7) Double Targeting :
• Temporal and spatial methodologies are combined
to target a carrier system, then targeting may be
called double targeting.
• Spatial placement relates to targeting drugs to
specific organs, tissues, cells or even subcellular
compartment. whereas temporal delivery refers to
controlling the rate of drug delivery to targetsite.
15. TYPES OF TARGETED DRUG DELIVERYSYSTEM
Nano Tubes : They are hollow cylinder made of
carbon, atoms which can be filled and sealed for
potential drug delivery.
Application : Cellular scale needle for attaching drug
molecule to cancer cells. As an electrode in thermo
cells.
17. Nanoshells : Nanoshells are hollow silica spheres
covered with gold. Scientists can attach antibodies to
their surfaces, enabling the shells to target certain
shells such as cancer cells.
Application : Technique has potential for targeting
cancerous drug.
20. protein markers associated with many forms of cancer,
including breast prostrate cancer.
Application : In cancer Treatment and Genetic
engineering.
22. Liposomes : Liposomes are simple microscopic vesicles
in which an aqueous volume is entirely composed by
membrane of lipid molecule various amphiphelic
molecules have been used to form liposomes. The
drug molecules can either be encapsulated in aqueous
space or intercalated into the lipid bilayers The extent
of location of drug will depend upon its physico-
chemical characteristics and composition of lipids.
Hydrophilic
Hy Hydrophobic
23. Niosomes : Niosomes are nonionic surfactant vesicles
which can entrap both hydrophilic and lipophilicdrugs
either in aqueous phase or in vesicular membrane made up
of lipid materials It is reported to attain betterstability
than liposome’s. It may prove very useful for targeting the
drugs for treating cancer, parasitic, viral and other
microbial disease more effectively.
24. Ufasomes : These are bilayer structures formed by
using single chain unsaturated fatty acids.
Pharmacosomes: The term pharmacosome comprises of
two main parts Pharmacon (active principle) and some
carriers postulated that amphipathic drug can self
assemble to form vesicle and these vesicles are termed
as pharmacosomes. Drug covalently bound to lipid may
exist in a colloidal dispersion as ultrafine, micelles or
hexagonal aggregates which are known as
pharmacosomes.
25. Virosomes : Virosomes are immuno modulating
liposomes consisting of surface glycoprotein of
influenza virus (immune stimulating reconstituted
influenza virosome) muramyl dipeptide etc. Virosomes
must be target oriented and their fusogenic
characteristics could be exploited in genome graftingand
cellular micro injection.
26. A. Interaction of the virosomes with cell surfacerecepters.
B. Release of the encapsulated drug molecules in the targetcell.
Targeteddrugdeliverysystem
27. Cubosomes : Cubosomes are liquid crystalline phase
forming small cubic particles suitable for injection.
Nanocrystals : Nanocrystal is any Nano material with at
least one dimension ≤ 100nm and that is single
crystalline. More properly, any material with a dimension
of less than 1 micrometre, i.e., 1000 nanometers, shouldbe
referred to as a nanoparticle, not a Nanocrystal. For
example, any particle which exhibits regions of
crystallinity should be termed nanoparticle or nanocluster
based on dimensions.
28. Nanobots : Nanorobotics is the technology of creating
machines or robots at or close to the microscopic scale
of a nanometer (10−9meters). More specifically,
nanorobotics refers to the still largely hypothetical
nanotechnology engineering discipline of designing and
building nanorobots, devices ranging in size from 0.1-10
micrometers and constructed of nano scale or molecular
components.
29. Transferosomes : A transferosomes, in functional terms,
may be described as lipid droplets of such deformability
that permits its easy penetration through the pores much
smaller than the droplets size.
•Transferosomes is a supramolecular entity that can pass
through a permeability barrier and there by transport
material from the other site.
•These are more elastic than standard liposomes.
